Opendata, web and dolomites

LiVirIn

3D Liver Organoids: Modelling Host Hepatitis B Virus Interaction

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LiVirIn project word cloud

Explore the words cloud of the LiVirIn project. It provides you a very rough idea of what is the project "LiVirIn" about.

biochemical    dna    covalently    risk    circular    cure    replication    tropism    conferences    nucleus    safe    closed    mobility    source    function    hepatocyte    hbv    inexhaustible    hepatic    3d    thinker    stable    meetings    chronically    enormous    causing    industry    narrow    400    form    potent    viral    worldwide    lost    delivers    presentations    carrier    cells    independent    pluripotent    liver    disseminated    biology    endothelial    inter    stellate    superior    reactivation    stem    engineering    hypothesis    transfer    an    disease    interdisciplinary    encompassing    drugs    vaccination    cccdna    hampered    knowledgeable    particles    virus    prevented    culture    suppression    biophysics    evaluation    peer    organoids    annually    models    vitro    train    chemotherapy    sinusoidal    infected    maturation    antiviral    lsecs    eradicate    medical    ing    wages    strategies    model    industries    matrix    appropriate    million    people    hscs    creation    boost    international    clinically    life    pscs    publications    hepatocytes    infection    hypothesize    animal    academia    hepatitis    pharmaceutical    biophysical    researcher    immune    completely    lack    expertise    mimics    efficacy    networking    human    scientific    658   

Project "LiVirIn" data sheet

The following table provides information about the project.

Coordinator
KATHOLIEKE UNIVERSITEIT LEUVEN 

Organization address
address: OUDE MARKT 13
city: LEUVEN
postcode: 3000
website: www.kuleuven.be

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Project website http://www.kuleuven.be/samenwerking/scil/about_us/livirin
 Total cost 172˙800 €
 EC max contribution 172˙800 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2014
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2015
 Duration (year-month-day) from 2015-03-01   to  2017-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KATHOLIEKE UNIVERSITEIT LEUVEN BE (LEUVEN) coordinator 172˙800.00

Map

 Project objective

An estimated ~400 million people are chronically infected with hepatitis B virus (HBV) infection worldwide, resulting in an estimated $658 million in medical costs and lost wages annually. Although HBV disease can be prevented by vaccination, many people still become infected. Potent and safe drugs are available to eradicate HBV viral particles and clinically ‘cure’ HBV infection. However, during replication HBV delivers a very stable form of viral DNA (covalently closed circular DNA, cccDNA) in the nucleus of the hepatocyte, causing life-long risk of reactivation of HBV infection in case of suppression of the immune system (e.g. chemotherapy). Therefore the pharmaceutical industry is now aiming to develop strategies to eradicate the virus from the infected liver completely. Such studies are hampered by the lack of appropriate in vitro or animal models due to the narrow tropism of HBV for human hepatocytes. The hypothesis of the project is that creation of 3D culture systems encompassing hepatocytes, hepatic stellate cells (HSCs) and liver sinusoidal endothelial cells (LSECs) derived from an inexhaustible source of cells (human pluripotent stem cells (PSCs)) in a matrix that mimics the biophysical and biochemical features of the liver, will be a superior model for the study of HBV infection and evaluation of the efficacy of antiviral drugs. We also hypothesize that such 3D organoids will improve maturation and function of hepatocytes, HSCs and LSECs. The proposed studies are highly interdisciplinary, merging expertise from biology, to biophysics and engineering, with inter-sector mobility, networking, collaboration and knowledge transfer between academia and industries. The knowledge developed will be disseminated by presentations at consortium meetings, international conferences and in peer publications. All these aspects will train the researcher as independent thinker, more knowledgeable in scientific research which will provide an enormous boost to his carrier.

 Publications

year authors and title journal last update
List of publications.
2016 M. Kumar, G. Rustandi, R. Boon, R. S. Patil, P. Roelandt, C. Verfaillie;
2016 TERMIS - Americas Conference and Exhibition San Diego, CA December 11–14, 2016
published pages: S-1-S-156, ISSN: 1937-3341, DOI: 10.1089/ten.tea.2016.5000.abstracts
Tissue Engineering Part A 22/S1 2019-07-24

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIVIRIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LIVIRIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

IRF4 Degradation (2019)

Using a novel protein degradation approach to uncover IRF4-regulated genes in plasma cells

Read More  

EVENTS (2020)

Affective work-related daily events, and changing characteristics of the work context: New challenges for management practices to deliver employees’ well-being and workplace performance

Read More  

InBPSOC (2020)

Increases biomass production and soil organic carbon stocks with innovative cropping systems under climate change

Read More